Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1976 Aug;73(8):2885–2889. doi: 10.1073/pnas.73.8.2885

Evidence for a gonadotropin from nonpregnant subjects that has physical, immunological, and biological similarities to human chorionic gonadotropin.

H C Chen, G D Hodgen, S Matsuura, L J Lin, E Gross, L E Reichert Jr, S Birken, R E Canfield, G T Ross
PMCID: PMC430789  PMID: 60763

Abstract

Substances from urinary extracts of normal, nonpregnant subjects and human pituitary gonadotropin preparations were found to react similarly to human chorionic gonadotropin (hCG) in a radioimmunoassay system that is highly specific for hCG and without crossreactivity to human luteinizing hormone (hLH). The antiserum was produced in a rabbit immunized with a bovine albumin conjugate of the unique carboxyl-terminal peptide (residues 123-145) isolated from a tryptic digest of the reduced, S-carboxymethylated hCGbeta subunit. The antibody recognition site on the peptide was found to reside on the last 15 amino acid residues of the carboxyl-terminal peptide, as evidenced by the competitive binding activities against 125I-labeled hCG of a series of peptides chemically synthesized according to the carboxyl-terminal sequence of HCGbeta. In order to elucidate the nature of the crossreacting substance in urinary extracts, a human postmenopausal urinary preparation (Pergonal) and a kaolin-acetone extract of urine from a patient with Klinefelter's syndrome were subjected to gel chromatography on Sephadex G-100. The results indicate that fractions showing immunocrossreactivity with the antiserum to hCGbeta-carboxyl-terminal peptide coeluted with 125I-labeled hCG which was separated distinctly from hLH. The same fractions from this postmenopausal urinary gonadotropin preparation exhibited in vitro biological activity proportional to the immunocrossreactivity of the hCG-specific antiserum. Concentration of postmenopausal women's urine by acetone precipitation retained approximately five times more immunoreactivity per unit volume than kaolin-acetone extraction, when assayed with the antiserum to hCGbeta-carboxyl-terminal peptide.

Full text

PDF
2885

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBERT A., DERNER I. Contamination of gonadotropin standards. J Clin Endocrinol Metab. 1960 Oct;20:1411–1416. doi: 10.1210/jcem-20-10-1411. [DOI] [PubMed] [Google Scholar]
  2. ALBERT A. Human urinary gonadotropin. Recent Prog Horm Res. 1956;12:227-96; discussion, 296-301. [PubMed] [Google Scholar]
  3. Braunstein G. D., Rasor J., Wade M. E. Presence in normal human testes of a chorionic-gonadotropin-like substance distinct from human luteinizing hormone. N Engl J Med. 1975 Dec 25;293(26):1339–1343. doi: 10.1056/NEJM197512252932603. [DOI] [PubMed] [Google Scholar]
  4. Braunstein G. D., Vaitukaitis J. L., Carbone P. P., Ross G. T. Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med. 1973 Jan;78(1):39–45. doi: 10.7326/0003-4819-78-1-39. [DOI] [PubMed] [Google Scholar]
  5. DONINI P., PUZZUOLI D., MONTEZEMOLO R. PURIFICATION OF GONADOTROPHIN FROM HUMAN MENOPAUSAL URINE. Acta Endocrinol (Copenh) 1964 Mar;45:321–328. doi: 10.1530/acta.0.0450321. [DOI] [PubMed] [Google Scholar]
  6. Dufau M. L., Mendelson C. R., Catt K. J. A highly sensitive in vitro bioassay for luteinizing hormone and chorionic gonadotropin: testosterone production by dispersed Leydig cells. J Clin Endocrinol Metab. 1974 Sep;39(3):610–613. doi: 10.1210/jcem-39-3-610. [DOI] [PubMed] [Google Scholar]
  7. Goldstein D. P., Kosasa T. S., Skarim A. T. The clinical application of a specific radioimmunoassay for human chorionic gondotropin in trophoblastic and nontrophoblastic tumors. Surg Gynecol Obstet. 1974 May;138(5):747–751. [PubMed] [Google Scholar]
  8. Hodgen G. D., Wilks J. W., Vaitukaitis J. L., Chen H. C., Papkoff H., Ross G. T. A new radioimmunoassay for follicle-stimulating hormone in macaques: ovulatory menstrual cycles. Endocrinology. 1976 Jul;99(1):137–145. doi: 10.1210/endo-99-1-137. [DOI] [PubMed] [Google Scholar]
  9. Louvet J. P., Ross G. T., Birken S., Canfield R. E. Absence of neutralizing effect of antisera to the unique structural region of human chorionic gonadotropin. J Clin Endocrinol Metab. 1974 Dec;39(6):1155–1158. doi: 10.1210/jcem-39-6-1155. [DOI] [PubMed] [Google Scholar]
  10. MERRIFIELD R. B. SOLID-PHASE PEPTIDE SYNTHESIS. 3. AN IMPROVED SYNTHESIS OF BRADYKININ. Biochemistry. 1964 Sep;3:1385–1390. doi: 10.1021/bi00897a032. [DOI] [PubMed] [Google Scholar]
  11. Morgan F. J., Birken S., Canfield R. E. Letter: Human chorionic gonadotropin: a proposal for the amino acid sequence. Mol Cell Biochem. 1973 Nov 15;2(1):97–99. doi: 10.1007/BF01738683. [DOI] [PubMed] [Google Scholar]
  12. Morgan F. J., Birken S., Canfield R. E. The amino acid sequence of human chorionic gonadotropin. The alpha subunit and beta subunit. J Biol Chem. 1975 Jul 10;250(13):5247–5258. [PubMed] [Google Scholar]
  13. Morgan F. J., Canfield R. E. Nature of the subunits of human chorionic gonadotropin. Endocrinology. 1971 Apr;88(4):1045–1053. doi: 10.1210/endo-88-4-1045. [DOI] [PubMed] [Google Scholar]
  14. Morgan F. J., Canfield R. E., Vaitukaitis J. L., Ross G. T. Properties of the subunits of human chorionic gonadotropin. Endocrinology. 1974 Jun;94(6):1601–1606. doi: 10.1210/endo-94-6-1601. [DOI] [PubMed] [Google Scholar]
  15. Odell W. D., Ross G. T., Rayford P. L. Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies. J Clin Invest. 1967 Feb;46(2):248–255. doi: 10.1172/JCI105527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rodbard D., Lewald J. E. Computer analysis of radioligand assay and radioimmunoassay data. Acta Endocrinol Suppl (Copenh) 1970;147:79–103. doi: 10.1530/acta.0.065s079. [DOI] [PubMed] [Google Scholar]
  17. Vaitukaitis J. L., Braunstein G. D., Ross G. T. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol. 1972 Jul 15;113(6):751–758. doi: 10.1016/0002-9378(72)90553-4. [DOI] [PubMed] [Google Scholar]
  18. Vaitukaitis J. L. Human chorionic gonadotropin as a tumor marker. Ann Clin Lab Sci. 1974 Jul-Aug;4(4):276–280. [PubMed] [Google Scholar]
  19. Vaitukaitis J., Robbins J. B., Nieschlag E., Ross G. T. A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab. 1971 Dec;33(6):988–991. doi: 10.1210/jcem-33-6-988. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES